PTPN1 and neoplasm: PTPN1 splice variants could up-regulated JAK/STAT activity in classic Hodgkin lymphoma cells, accelerated tumor cell proliferation, and reduced the toxicity effect of chemotherapy drugs such as gessabine and oroposide (34, 35).